Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027
The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%.
Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.
The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Growth in this market is largely driven by the increasing use of endoscopy in detection and treatment procedures, the rising prevalence of cancer, and the growing geriatric population. On the other hand, the dearth of skilled professionals is a key factor restraining the growth of this market.
The gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market
In 2021, the gastroscopes and colonoscopes segment holds the largest share of the global endoscopic submucosal dissection market. The large share of this segment can be attributed to the higher adoption rate of this equipment by end users, the rising preference of patients and doctors for minimally invasive procedures, and ongoing technological advancements in endoscopy procedures.
The stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021
Based on indication, the endoscopic submucosal dissection market is segmented into esophageal cancer stomach cancer, colon cancer. The stomach cancer segment holds the largest share of the endoscopic submucosal dissection market in 2021. The large share of this segment can be attributed to the increasing geriatric population in the US, China, Japan, and India and the rising incidence of stomach cancer.
The hospitals' segment is expected to dominate the endoscopic submucosal dissection market during the forecast period
Based on end user, the endoscopic submucosal dissection market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and other end users. The hospitals segment holds the largest share of the endoscopic submucosal dissection market during the forecast period owing to the the increasing per capita income and growing healthcare awareness.
North America dominated the endoscopic submucosal dissection market in 2021
North America dominated the endoscopic submucosal dissection market in 2021. The large share of North America in the global market is attributed to the favorable reimbursement policies for endoscopic procedures in the US, the increasing prevalence of cancer, high investments by hospitals to purchase new equipment and adopt new endoscopic procedures, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals.
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
The prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group PLC (UK), Medtronic (Ireland), HOYA Corporation (Japan), ConMed Corporation (US), Steris Plc (Ireland), FUJIFILM Holdings Corporation (Japan), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & CO. KG (Germany), Cook Medical (US), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), DCC Healthcare Limited (Ireland), Kossen Co., Ltd. (South Korea), INNOVAMEDICA S.p.A. (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS Medical Technological Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).
Research Coverage:
The report analyzes the endoscopic submucosal dissection market and aims at estimating the market size and future growth potential of this market based on various segments such asproduct, indication, end user and region. The report also includes a product portfolio matrix of various endoscopic submucosal dissection products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.
The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Growth in this market is largely driven by the increasing use of endoscopy in detection and treatment procedures, the rising prevalence of cancer, and the growing geriatric population. On the other hand, the dearth of skilled professionals is a key factor restraining the growth of this market.
The gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market
In 2021, the gastroscopes and colonoscopes segment holds the largest share of the global endoscopic submucosal dissection market. The large share of this segment can be attributed to the higher adoption rate of this equipment by end users, the rising preference of patients and doctors for minimally invasive procedures, and ongoing technological advancements in endoscopy procedures.
The stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021
Based on indication, the endoscopic submucosal dissection market is segmented into esophageal cancer stomach cancer, colon cancer. The stomach cancer segment holds the largest share of the endoscopic submucosal dissection market in 2021. The large share of this segment can be attributed to the increasing geriatric population in the US, China, Japan, and India and the rising incidence of stomach cancer.
The hospitals' segment is expected to dominate the endoscopic submucosal dissection market during the forecast period
Based on end user, the endoscopic submucosal dissection market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and other end users. The hospitals segment holds the largest share of the endoscopic submucosal dissection market during the forecast period owing to the the increasing per capita income and growing healthcare awareness.
North America dominated the endoscopic submucosal dissection market in 2021
North America dominated the endoscopic submucosal dissection market in 2021. The large share of North America in the global market is attributed to the favorable reimbursement policies for endoscopic procedures in the US, the increasing prevalence of cancer, high investments by hospitals to purchase new equipment and adopt new endoscopic procedures, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals.
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
- By Company Type– Tier 1- 34%, Tier 2- 38% Tier 3 - 28%
- By Designation— C level - 26%, Managers & Other Level - 74%
- By Region— North America - 17%, Europe - 39%, Asia Pacific - 28%
The prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group PLC (UK), Medtronic (Ireland), HOYA Corporation (Japan), ConMed Corporation (US), Steris Plc (Ireland), FUJIFILM Holdings Corporation (Japan), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & CO. KG (Germany), Cook Medical (US), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), DCC Healthcare Limited (Ireland), Kossen Co., Ltd. (South Korea), INNOVAMEDICA S.p.A. (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS Medical Technological Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).
Research Coverage:
The report analyzes the endoscopic submucosal dissection market and aims at estimating the market size and future growth potential of this market based on various segments such asproduct, indication, end user and region. The report also includes a product portfolio matrix of various endoscopic submucosal dissection products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global endoscopic submucosal dissection market. The report analyzes this market by product, indication, end user and region.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoscopic submucosal dissection market.
- Market Development: Comprehensive information on the lucrative emerging markets byproduct, indication, end user and region.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoscopic submucosal dissection market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoscopic submucosal dissection market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.6 SCOPE-RELATED LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2021)
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 12 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
3 EXECUTIVE SUMMARY
FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
4 PREMIUM INSIGHTS
4.1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW
FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY
FIGURE 19 GASTROSCOPES AND COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
4.3 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX
FIGURE 20 MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: REGIONAL MIX
FIGURE 21 NORTH AMERICA TO BE LARGEST MARKET FOR ENDOSCOPIC SUBMUCOSAL DISSECTION PRODUCTS THROUGHOUT FORECAST PERIOD
4.5 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing use of endoscopy in detection and treatment procedures
5.2.1.2 Rising prevalence of cancer
FIGURE 24 GLOBAL CANCER INCIDENCE, 2008–2030
5.2.1.3 Growing geriatric population
FIGURE 25 SHARE OF GERIATRIC POPULATION, BY REGION (2010–2030)
TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 2040
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled professionals
5.2.2.2 High overhead cost of ESD procedures with limited reimbursements
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for minimally invasive procedures
5.2.3.2 Growing investments in research and development of endoscopy technology
TABLE 4 MAJOR DEVELOPMENTS
5.2.3.3 Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries
5.2.4 CHALLENGES
5.2.4.1 Higher rate of complications
5.2.4.2 Risk of post-operative infection
5.3 INDUSTRY TRENDS
5.3.1 ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION
5.3.2 ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION
5.4 REGULATORY ANALYSIS
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.2 NORTH AMERICA
5.4.2.1 US
5.4.2.2 Canada
5.4.3 EUROPE
5.4.3.1 Germany
5.4.3.2 France
5.4.3.3 UK
5.4.3.4 Italy
5.5 ECOSYSTEM MARKET MAP
FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM MARKET MAP
5.6 VALUE CHAIN ANALYSIS
FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.1.1 High capital requirement
5.7.1.2 High preference for products from well-established brands
5.7.2 THREAT OF SUBSTITUTES
5.7.2.1 Presence of substitute therapies for endoscopic submucosal dissection
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.3.1 Presence of several raw material suppliers
5.7.3.2 Supplier switching cost
5.7.4 BARGAINING POWER OF BUYERS
5.7.4.1 Limited number of companies offering premium products at global level
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.7.5.1 Increasing demand for high-quality and innovative products
5.7.5.2 Lucrative growth potential in emerging markets
5.8 INDICATIVE PRICING MODEL ANALYSIS
TABLE 9 AVERAGE SELLING PRICE, BY PRODUCT (USD)
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022
5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS
FIGURE 29 TOP COMPANIES THAT APPLIED FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS, 2015–2022
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022
5.10 SUPPLY CHAIN ANALYSIS
FIGURE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN
5.11 KEY CONFERENCES AND EVENTS DURING 2022–2023
TABLE 10 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
5.12.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 13 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 GASTROSCOPES AND COLONOSCOPES
6.2.1 RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH
TABLE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GASTROSCOPES AND COLONOSCOPES, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 KNIVES
6.3.1 IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH
TABLE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR KNIVES, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 INJECTION AGENTS
6.4.1 NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH
TABLE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR INJECTION AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 TISSUE RETRACTORS
6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION OF TISSUE RETRACTORS
TABLE 17 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR TISSUE RETRACTORS, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 GRASPERS/CLIPS
6.6.1 PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE THEIR DEMAND
TABLE 18 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GRASPERS/CLIPS, BY COUNTRY, 2020–2027 (USD MILLION)
6.7 OTHER PRODUCTS
TABLE 19 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION
7.1 INTRODUCTION
TABLE 20 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2021 (NUMBER OF PROCEDURES)
7.2 STOMACH CANCER
7.2.1 STOMACH CANCER OR GASTRIC CANCER ASSOCIATED WITH SIGNIFICANT PROPORTION OF ALL CANCER DEATHS
TABLE 22 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020–2040)
TABLE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 24 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
7.3 COLON CANCER
7.3.1 COLON CANCER IS THIRD-MOST-COMMON CANCER AND SECOND-LEADING CAUSE OF CANCER DEATHS WORLDWIDE
TABLE 25 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2020–2040)
TABLE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
7.4 ESOPHAGEAL CANCER
7.4.1 GROWING PREVALENCE OF ESOPHAGEAL CANCER ATTRIBUTED TO EXCESS TOBACCO AND ALCOHOL USE
TABLE 28 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020–2040)
TABLE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER
8.1 INTRODUCTION
TABLE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH
TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 SPECIALTY CLINICS
8.3.1 TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH
TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 AMBULATORY SURGICAL CENTERS
8.4.1 GROWTH IN ASC SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS
TABLE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
TABLE 37 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 38 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 US is largest market for endoscopic submucosal dissection products
TABLE 41 US: MACROECONOMIC INDICATORS
TABLE 42 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 43 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 44 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Slower healthcare development in Canada over past decade to restrain growth
TABLE 45 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040
TABLE 46 CANADA: MACROECONOMIC INDICATORS
TABLE 47 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 48 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 49 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 50 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 52 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 53 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany to account for largest share of European market
TABLE 54 GERMANY: MACROECONOMIC INDICATORS
TABLE 55 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 56 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 57 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 High-quality healthcare system offering coverage to all citizens to support market growth
TABLE 58 FRANCE: MACROECONOMIC INDICATORS
TABLE 59 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 61 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 UK
9.3.3.1 Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market
TABLE 62 UK: MACROECONOMIC INDICATORS
TABLE 63 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 64 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 65 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Receptivity of government toward high-quality and technologically advanced equipment to foster growth
TABLE 66 ITALY: MACROECONOMIC INDICATORS
TABLE 67 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 68 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 69 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising prevalence of cancer to drive market growth
TABLE 70 SPAIN: MACROECONOMIC INDICATORS
TABLE 71 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 72 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 73 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 74 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 75 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 76 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 36 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
TABLE 77 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 78 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 79 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 80 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Supportive medical device reimbursement policies to drive market growth
TABLE 81 JAPAN: MACROECONOMIC INDICATORS
TABLE 82 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 83 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 84 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Large patient population and strong need for healthcare infrastructure improvements to boost market growth
TABLE 85 CHINA: MACROECONOMIC INDICATORS
TABLE 86 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 87 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 88 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Favorable government initiatives for healthcare infrastructure improvements to support market growth
TABLE 89 INDIA: MACROECONOMIC INDICATORS
TABLE 90 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 91 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 92 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 93 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 94 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 95 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY WILL FAVOR MARKET GROWTH
TABLE 96 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 97 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 98 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 HEALTHCARE INFRASTRUCTURAL ADVANCEMENTS WILL CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES
TABLE 99 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 100 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
10.3 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER (2021)
10.5 COMPANY FOOTPRINT ANALYSIS
10.5.1 FOOTPRINT OF COMPANIES, BY PRODUCT
10.5.2 FOOTPRINT OF COMPANIES, BY END USER
10.5.3 FOOTPRINT OF COMPANIES, BY REGION
10.6 COMPANY EVALUATION MATRIX
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX
10.7 COMPETITIVE BENCHMARKING
TABLE 102 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY START-UPS/SMES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 103 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2022)
10.8.2 DEALS
TABLE 104 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS (JANUARY 2019–DECEMBER 2022)
10.8.3 OTHER DEVELOPMENTS
TABLE 105 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: OTHER DEVELOPMENTS (JANUARY 2019–DECEMBER 2022)
11 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
TABLE 106 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 40 COMPANY SNAPSHOT: OLYMPUS CORPORATION (2022)
11.1.2 FUJIFILM HOLDINGS CORPORATION
TABLE 107 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 41 COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021)
11.1.3 BOSTON SCIENTIFIC CORPORATION
TABLE 108 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 42 COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION (2021)
11.1.4 MEDTRONIC
TABLE 109 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 43 COMPANY SNAPSHOT: MEDTRONIC (2022)
11.1.5 SUMITOMO BAKELITE CO., LTD.
TABLE 110 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW
FIGURE 44 COMPANY SNAPSHOT: SUMITOMO BAKELITE CO., LTD. (2021)
11.1.6 CREO MEDICAL GROUP PLC
TABLE 111 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW
FIGURE 45 COMPANY SNAPSHOT: CREO MEDICAL GROUP PLC (2021)
11.1.7 HOYA CORPORATION
TABLE 112 HOYA CORPORATION: BUSINESS OVERVIEW
FIGURE 46 COMPANY SNAPSHOT: HOYA CORPORATION (2022)
11.1.8 CONMED CORPORATION
TABLE 113 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 47 COMPANY SNAPSHOT: CONMED CORPORATION (2021)
11.1.9 STERIS PLC
TABLE 114 STERIS PLC: BUSINESS OVERVIEW
FIGURE 48 COMPANY SNAPSHOT: STERIS PLC (2022)
11.1.10 MTW ENDOSKOPIE MANUFAKTUR
TABLE 115 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 OVESCO ENDOSCOPY AG
TABLE 116 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW
11.2.2 ZEON MEDICAL INC.
TABLE 117 ZEON MEDICAL INC.: BUSINESS OVERVIEW
11.2.3 MICRO-TECH ENDOSCOPY
TABLE 118 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW
11.2.4 KARL STORZ SE & CO. KG
TABLE 119 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW
11.2.5 COOK MEDICAL
TABLE 120 COOK MEDICAL: BUSINESS OVERVIEW
11.2.6 LEO MEDICAL CO., LTD.
TABLE 121 LEO MEDICAL CO., LTD.: BUSINESS OVERVIEW
11.2.7 ERBE ELEKTROMEDIZIN GMBH
TABLE 122 ERBE ELEKTROMEDIZIN GMBH: BUSINESS OVERVIEW
11.2.8 TAEWOONG MEDICAL CO., LTD.
TABLE 123 TAEWOONG MEDICAL CO., LTD.: BUSINESS OVERVIEW
11.2.9 DCC HEALTHCARE LIMITED
TABLE 124 DCC HEALTHCARE LIMITED: BUSINESS OVERVIEW
11.2.10 KOSSEN CO., LTD.
TABLE 125 KOSSEN CO., LTD.: BUSINESS OVERVIEW
11.2.11 INNOVAMEDICA S.P.A.
TABLE 126 INNOVAMEDICA S.P.A.: BUSINESS OVERVIEW
11.2.12 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
TABLE 127 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
11.2.13 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.
TABLE 128 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: BUSINESS OVERVIEW
11.2.14 BEIJING ZKSK TECHNOLOGY CO., LTD.
TABLE 129 BEIJING ZKSK TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.6 SCOPE-RELATED LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2021)
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 12 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
3 EXECUTIVE SUMMARY
FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
4 PREMIUM INSIGHTS
4.1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW
FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY
FIGURE 19 GASTROSCOPES AND COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
4.3 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX
FIGURE 20 MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.4 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: REGIONAL MIX
FIGURE 21 NORTH AMERICA TO BE LARGEST MARKET FOR ENDOSCOPIC SUBMUCOSAL DISSECTION PRODUCTS THROUGHOUT FORECAST PERIOD
4.5 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing use of endoscopy in detection and treatment procedures
5.2.1.2 Rising prevalence of cancer
FIGURE 24 GLOBAL CANCER INCIDENCE, 2008–2030
5.2.1.3 Growing geriatric population
FIGURE 25 SHARE OF GERIATRIC POPULATION, BY REGION (2010–2030)
TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 2040
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled professionals
5.2.2.2 High overhead cost of ESD procedures with limited reimbursements
5.2.3 OPPORTUNITIES
5.2.3.1 Growing demand for minimally invasive procedures
5.2.3.2 Growing investments in research and development of endoscopy technology
TABLE 4 MAJOR DEVELOPMENTS
5.2.3.3 Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries
5.2.4 CHALLENGES
5.2.4.1 Higher rate of complications
5.2.4.2 Risk of post-operative infection
5.3 INDUSTRY TRENDS
5.3.1 ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION
5.3.2 ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION
5.4 REGULATORY ANALYSIS
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.2 NORTH AMERICA
5.4.2.1 US
5.4.2.2 Canada
5.4.3 EUROPE
5.4.3.1 Germany
5.4.3.2 France
5.4.3.3 UK
5.4.3.4 Italy
5.5 ECOSYSTEM MARKET MAP
FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM MARKET MAP
5.6 VALUE CHAIN ANALYSIS
FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.1.1 High capital requirement
5.7.1.2 High preference for products from well-established brands
5.7.2 THREAT OF SUBSTITUTES
5.7.2.1 Presence of substitute therapies for endoscopic submucosal dissection
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.3.1 Presence of several raw material suppliers
5.7.3.2 Supplier switching cost
5.7.4 BARGAINING POWER OF BUYERS
5.7.4.1 Limited number of companies offering premium products at global level
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.7.5.1 Increasing demand for high-quality and innovative products
5.7.5.2 Lucrative growth potential in emerging markets
5.8 INDICATIVE PRICING MODEL ANALYSIS
TABLE 9 AVERAGE SELLING PRICE, BY PRODUCT (USD)
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022
5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS
FIGURE 29 TOP COMPANIES THAT APPLIED FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS, 2015–2022
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022
5.10 SUPPLY CHAIN ANALYSIS
FIGURE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN
5.11 KEY CONFERENCES AND EVENTS DURING 2022–2023
TABLE 10 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
5.12.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 13 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 GASTROSCOPES AND COLONOSCOPES
6.2.1 RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH
TABLE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GASTROSCOPES AND COLONOSCOPES, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 KNIVES
6.3.1 IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH
TABLE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR KNIVES, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 INJECTION AGENTS
6.4.1 NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH
TABLE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR INJECTION AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 TISSUE RETRACTORS
6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION OF TISSUE RETRACTORS
TABLE 17 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR TISSUE RETRACTORS, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 GRASPERS/CLIPS
6.6.1 PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE THEIR DEMAND
TABLE 18 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GRASPERS/CLIPS, BY COUNTRY, 2020–2027 (USD MILLION)
6.7 OTHER PRODUCTS
TABLE 19 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION
7.1 INTRODUCTION
TABLE 20 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2021 (NUMBER OF PROCEDURES)
7.2 STOMACH CANCER
7.2.1 STOMACH CANCER OR GASTRIC CANCER ASSOCIATED WITH SIGNIFICANT PROPORTION OF ALL CANCER DEATHS
TABLE 22 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020–2040)
TABLE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 24 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
7.3 COLON CANCER
7.3.1 COLON CANCER IS THIRD-MOST-COMMON CANCER AND SECOND-LEADING CAUSE OF CANCER DEATHS WORLDWIDE
TABLE 25 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2020–2040)
TABLE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
7.4 ESOPHAGEAL CANCER
7.4.1 GROWING PREVALENCE OF ESOPHAGEAL CANCER ATTRIBUTED TO EXCESS TOBACCO AND ALCOHOL USE
TABLE 28 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020–2040)
TABLE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER
8.1 INTRODUCTION
TABLE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH
TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 SPECIALTY CLINICS
8.3.1 TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH
TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 AMBULATORY SURGICAL CENTERS
8.4.1 GROWTH IN ASC SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS
TABLE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
TABLE 37 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 38 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 US is largest market for endoscopic submucosal dissection products
TABLE 41 US: MACROECONOMIC INDICATORS
TABLE 42 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 43 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 44 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Slower healthcare development in Canada over past decade to restrain growth
TABLE 45 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040
TABLE 46 CANADA: MACROECONOMIC INDICATORS
TABLE 47 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 48 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 49 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 50 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 52 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 53 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany to account for largest share of European market
TABLE 54 GERMANY: MACROECONOMIC INDICATORS
TABLE 55 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 56 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 57 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 High-quality healthcare system offering coverage to all citizens to support market growth
TABLE 58 FRANCE: MACROECONOMIC INDICATORS
TABLE 59 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 61 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 UK
9.3.3.1 Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market
TABLE 62 UK: MACROECONOMIC INDICATORS
TABLE 63 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 64 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 65 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Receptivity of government toward high-quality and technologically advanced equipment to foster growth
TABLE 66 ITALY: MACROECONOMIC INDICATORS
TABLE 67 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 68 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 69 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising prevalence of cancer to drive market growth
TABLE 70 SPAIN: MACROECONOMIC INDICATORS
TABLE 71 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 72 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 73 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 74 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 75 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 76 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 36 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
TABLE 77 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 78 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 79 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 80 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Supportive medical device reimbursement policies to drive market growth
TABLE 81 JAPAN: MACROECONOMIC INDICATORS
TABLE 82 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 83 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 84 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Large patient population and strong need for healthcare infrastructure improvements to boost market growth
TABLE 85 CHINA: MACROECONOMIC INDICATORS
TABLE 86 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 87 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 88 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Favorable government initiatives for healthcare infrastructure improvements to support market growth
TABLE 89 INDIA: MACROECONOMIC INDICATORS
TABLE 90 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 91 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 92 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 93 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 94 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 95 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY WILL FAVOR MARKET GROWTH
TABLE 96 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 97 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 98 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 HEALTHCARE INFRASTRUCTURAL ADVANCEMENTS WILL CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES
TABLE 99 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 100 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
10.3 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER (2021)
10.5 COMPANY FOOTPRINT ANALYSIS
10.5.1 FOOTPRINT OF COMPANIES, BY PRODUCT
10.5.2 FOOTPRINT OF COMPANIES, BY END USER
10.5.3 FOOTPRINT OF COMPANIES, BY REGION
10.6 COMPANY EVALUATION MATRIX
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
FIGURE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX
10.7 COMPETITIVE BENCHMARKING
TABLE 102 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY START-UPS/SMES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 103 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2022)
10.8.2 DEALS
TABLE 104 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS (JANUARY 2019–DECEMBER 2022)
10.8.3 OTHER DEVELOPMENTS
TABLE 105 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: OTHER DEVELOPMENTS (JANUARY 2019–DECEMBER 2022)
11 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
TABLE 106 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 40 COMPANY SNAPSHOT: OLYMPUS CORPORATION (2022)
11.1.2 FUJIFILM HOLDINGS CORPORATION
TABLE 107 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 41 COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021)
11.1.3 BOSTON SCIENTIFIC CORPORATION
TABLE 108 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 42 COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION (2021)
11.1.4 MEDTRONIC
TABLE 109 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 43 COMPANY SNAPSHOT: MEDTRONIC (2022)
11.1.5 SUMITOMO BAKELITE CO., LTD.
TABLE 110 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW
FIGURE 44 COMPANY SNAPSHOT: SUMITOMO BAKELITE CO., LTD. (2021)
11.1.6 CREO MEDICAL GROUP PLC
TABLE 111 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW
FIGURE 45 COMPANY SNAPSHOT: CREO MEDICAL GROUP PLC (2021)
11.1.7 HOYA CORPORATION
TABLE 112 HOYA CORPORATION: BUSINESS OVERVIEW
FIGURE 46 COMPANY SNAPSHOT: HOYA CORPORATION (2022)
11.1.8 CONMED CORPORATION
TABLE 113 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 47 COMPANY SNAPSHOT: CONMED CORPORATION (2021)
11.1.9 STERIS PLC
TABLE 114 STERIS PLC: BUSINESS OVERVIEW
FIGURE 48 COMPANY SNAPSHOT: STERIS PLC (2022)
11.1.10 MTW ENDOSKOPIE MANUFAKTUR
TABLE 115 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 OVESCO ENDOSCOPY AG
TABLE 116 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW
11.2.2 ZEON MEDICAL INC.
TABLE 117 ZEON MEDICAL INC.: BUSINESS OVERVIEW
11.2.3 MICRO-TECH ENDOSCOPY
TABLE 118 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW
11.2.4 KARL STORZ SE & CO. KG
TABLE 119 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW
11.2.5 COOK MEDICAL
TABLE 120 COOK MEDICAL: BUSINESS OVERVIEW
11.2.6 LEO MEDICAL CO., LTD.
TABLE 121 LEO MEDICAL CO., LTD.: BUSINESS OVERVIEW
11.2.7 ERBE ELEKTROMEDIZIN GMBH
TABLE 122 ERBE ELEKTROMEDIZIN GMBH: BUSINESS OVERVIEW
11.2.8 TAEWOONG MEDICAL CO., LTD.
TABLE 123 TAEWOONG MEDICAL CO., LTD.: BUSINESS OVERVIEW
11.2.9 DCC HEALTHCARE LIMITED
TABLE 124 DCC HEALTHCARE LIMITED: BUSINESS OVERVIEW
11.2.10 KOSSEN CO., LTD.
TABLE 125 KOSSEN CO., LTD.: BUSINESS OVERVIEW
11.2.11 INNOVAMEDICA S.P.A.
TABLE 126 INNOVAMEDICA S.P.A.: BUSINESS OVERVIEW
11.2.12 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
TABLE 127 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
11.2.13 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.
TABLE 128 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: BUSINESS OVERVIEW
11.2.14 BEIJING ZKSK TECHNOLOGY CO., LTD.
TABLE 129 BEIJING ZKSK TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
